⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for estrogen blocker

Every month we try and update this database with for estrogen blocker cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerNCT00097344
Breast Neoplasm...
Neoplasms, Horm...
Atamestane
Toremifene
Letrozole
Aromatase inhib...
Estrogen recept...
Hormone therapy
Endocrine thera...
Antiestrogen th...
18 Years - Intarcia Therapeutics
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerNCT00097344
Breast Neoplasm...
Neoplasms, Horm...
Atamestane
Toremifene
Letrozole
Aromatase inhib...
Estrogen recept...
Hormone therapy
Endocrine thera...
Antiestrogen th...
18 Years - Intarcia Therapeutics
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerNCT00044291
Breast Neoplasm...
Neoplasms, Horm...
atamestane
toremifene
letrozole
aromatase inhib...
hormone therapy
endocrine thera...
antiestrogen th...
18 Years - Intarcia Therapeutics
Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast CancerNCT00267553
Breast Neoplasm...
Neoplasms, Horm...
Atamestane
toremifene
letrozole
18 Years - Intarcia Therapeutics
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: